ArticleJournal for immunotherapy of cancer2025

Tumor-infiltrating mast cells as potential chemoimmunotherapy enhancer in triple-negative breast cancer.

Pinchao Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.